A resource for producing medical isotopes to aid in diagnosing and treating diseases.
A National, Theranostic Cyclotron Resource to Drive Fundamental and Translational Medical Science
['FUNDING_OTHER'] · UNIVERSITY OF WISCONSIN-MADISON · NIH-10795184
This study is about building a new facility at the University of Wisconsin-Madison to create special medical materials that help doctors see and treat conditions like Alzheimer's and cancer, so patients can get better and more personalized care.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF WISCONSIN-MADISON (nih funded) |
| Locations | 1 site (MADISON, UNITED STATES) |
| Trial ID | NIH-10795184 on ClinicalTrials.gov |
What this research studies
This research focuses on establishing a new cyclotron facility at the University of Wisconsin-Madison to produce radionuclides used in medical imaging and treatment. By enhancing the production capacity of various isotopes, including those for Alzheimer's disease and cancers, the project aims to support both fundamental and translational medical science. Patients may benefit from improved diagnostic tools and targeted therapies that utilize these radionuclides, which are essential for advancing personalized medicine. The facility will cater to a wide range of clinical and research applications, addressing the growing demand for these critical resources.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit include individuals diagnosed with Alzheimer's disease or cancers requiring advanced imaging and treatment options.
Not a fit: Patients with conditions unrelated to Alzheimer's disease or cancer may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to better diagnostic and therapeutic options for patients with Alzheimer's disease and various cancers.
How similar studies have performed: Previous research has shown success in using cyclotron-produced radionuclides for medical applications, indicating a promising approach for this project.
Where this research is happening
MADISON, UNITED STATES
- UNIVERSITY OF WISCONSIN-MADISON — MADISON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GOLDEN, ROBERT NEAL — UNIVERSITY OF WISCONSIN-MADISON
- Study coordinator: GOLDEN, ROBERT NEAL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease, Cancers